Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer

被引:29
|
作者
Komaki, R
Milas, L
Ro, JY
Fujii, T
Perkins, P
Allen, P
Sikes, CR
Mountain, CF
Ordonez, NG
机构
[1] Univ Texas, MD Anderson Cancer Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Cancer Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Cancer Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Cancer Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA
关键词
non-small-cell lung cancer; pathological N1; biomarkers; prognostic factors;
D O I
10.1016/S0360-3016(97)00898-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The prognostic influence of 6 biomarkers correlated to histologic subtypes of non-small cell lung cancer (NSCLC) on loco-regional control, overall survival, disease-free survival (DFS), and distant disease control (DDC) rates, all measured at 5 years, were examined. Materials & Methods: Cell blocks from the primary tumors of 137 patients with pathologically staged N1 NSCLC at MDACC were analyzed by 6-biomarker status correlated to histological subtypes and their outcomes. Results: The ranges of biomarker values were as follows: apoptotic index, 0.2-2.8%; mitotic index, 0-1.8%; the proportion of cells in S+G2M, 3-36%; p53 status, 0-100%; Ki-67, 0-9.3%; DNA index, 1.0-2.74. Subtypes of 137 cases from the postoperative pathology specimen showed that 74 patients had squamous carcinoma and 63 patients had adenocarcinoma. Mean and median lengths of follow-up were 4.21 years and 2.43 years, respectively. Patients with squamous cell carcinoma (SCC) had a better 5-year survival (p = 0.006), DFS (p = 0.002), and distant metastasis control (p = 0.002) than patients with adenocarcinoma (AC). Among'patients with AC, the DNA index was a significant predictor of 5-year DFS (p = 0.02), DDC rate (p = 0.04), and local-regional control (p < 0.05). Higher apoptosis (p = 0.03) and mitosis indices (p = 0.03) were also univariate predictors of increased distant disease among patients with AC. Multivariate analysis of patients with AC revealed that the DNA index and Ki-67 were the only significant independent predictors of distant metastasis (p < 0.04 and p < 0.02, respectively) and DFS (p < 0.04 for both). Among patients with SCC, univariate analysis showed that S+G2M proportion (p < 0.05) and Ki-67 levels (p < 0.02) were significant predictors for local-regional control; for SC, multivariate analysis showed that only mitosis was a significant predictor in this case for overall survival (p < 0.04). Conclusion: Spontaneous apoptotic index and Ki-67 were significantly higher in SC than in AC. Patients with SC had less distant metastasis better DFS and overall survival than those with AC. Multivariate analysis revealed that DNA index and Ki-67 status were significant predictors for DDC and DFS in patients with AC, but only mitotic index was a significant predictor of overall survival for patients with SCC. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:787 / 796
页数:10
相关论文
共 50 条
  • [1] Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non-small cell lung cancer
    Komaki, RU
    Perkins, P
    Fujii, T
    Ro, JY
    Ordenez, NG
    Mountain, C
    RADIOLOGY, 1996, 201 : 1497 - 1497
  • [2] Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer
    Komaki, R
    Fujii, T
    Perkins, P
    Ro, JY
    Allen, PK
    Mason, KA
    Mountain, CF
    Milas, L
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (03): : 601 - 605
  • [3] Tumor biomarkers in lung cancer: an analysis of patients with pathologically staged N1 non-small cell lung cancer (vol 201, pg 405, 1996)
    Komaki, R. U.
    Fujii, T.
    Ro, J. Y.
    Ordonez, N. G.
    Mountain, C.
    RADIOLOGY, 2011, 261 (02) : 665 - 665
  • [4] Prognostic factors after surgical resection of N1 non-small cell lung cancer
    Mordant, P.
    Pricopi, C.
    Legras, A.
    Arame, A.
    Foucault, C.
    Dujon, A.
    Le Pimpec-Barthes, F.
    Riquet, M.
    EJSO, 2015, 41 (05): : 696 - 701
  • [5] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Masaya Tamura
    Isao Matsumoto
    Yusuke Tanaka
    Daisuke Saito
    Shuhei Yoshida
    Munehisa Takata
    Hirofumi Takemura
    General Thoracic and Cardiovascular Surgery, 2020, 68 : 261 - 265
  • [6] Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer
    Tamura, Masaya
    Matsumoto, Isao
    Tanaka, Yusuke
    Saito, Daisuke
    Yoshida, Shuhei
    Takata, Munehisa
    Takemura, Hirofumi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (03) : 261 - 265
  • [7] Heterogeneity of Clinical N1 Non-Small Cell Lung Cancer
    Kim, Dohun
    Choi, Yong Soo
    Kim, Hong Kwan
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    THORACIC AND CARDIOVASCULAR SURGEON, 2014, 62 (02): : 103 - 108
  • [8] Osteopontin is a prognostic biomarker in non-small cell lung cancer
    Rud, Ane Kongsgaard
    Boye, Kjetil
    Oijordsbakken, Miriam
    Lund-Iversen, Marius
    Halvorsen, Ann Rita
    Solberg, Steinar K.
    Berge, Gisle
    Helland, Aslaug
    Brustugun, Odd Terje
    Maelandsmo, Gunhild M.
    BMC CANCER, 2013, 13
  • [9] LRIG1 is a prognostic biomarker in non-small cell lung cancer
    Kvarnbrink, Samuel
    Karlsson, Terese
    Edlund, Karolina
    Botling, Johan
    Lindquist, David
    Jirstrom, Karin
    Micke, Patrick
    Henriksson, Roger
    Johansson, Mikael
    Hedman, Hakan
    ACTA ONCOLOGICA, 2015, 54 (08) : 1113 - 1119
  • [10] Tumor biomarkers in lung cancer: An analysis of patients with pathologically staged N1 non small cell lung cancer (NSCLC) (vol 18, pg 160, 1997)
    Komaki, R.
    Milas, L.
    Fujii, T.
    Jay, Ro
    Alan, P.
    El-Naggar, A. K.
    Mountain, C.
    Ordonez, N. G.
    LUNG CANCER, 2013, 81 (03) : 497 - 497